BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 20620438)

  • 1. Use of thrombopoietic agents for the thrombocytopenia of liver disease.
    Tillmann HL; McHutchison JG
    Semin Hematol; 2010 Jul; 47(3):266-73. PubMed ID: 20620438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review article: thrombocytopenia in chronic liver disease and pharmacologic treatment options.
    Giannini EG
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1055-65. PubMed ID: 16611265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombocytopenia associated with chronic liver disease.
    Afdhal N; McHutchison J; Brown R; Jacobson I; Manns M; Poordad F; Weksler B; Esteban R
    J Hepatol; 2008 Jun; 48(6):1000-7. PubMed ID: 18433919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review article: pharmacological approaches for the treatment of thrombocytopenia in patients with chronic liver disease and hepatitis C infection.
    Afdhal NH; McHutchison JG
    Aliment Pharmacol Ther; 2007 Nov; 26 Suppl 1():29-39. PubMed ID: 17958517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombopoietin mimetic agents in the management of immune thrombocytopenic purpura.
    Newland A
    Semin Hematol; 2007 Oct; 44(4 Suppl 5):S35-45. PubMed ID: 18096471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in the treatment of hepatitis C.
    Lawrence SP
    Adv Intern Med; 2000; 45():65-105. PubMed ID: 10635046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum thrombopoietin in chronic liver disease: relation to severity of the disease and spleen size.
    Freni MA; Spadaro A; Ajello A; Barbaro E; Scaffidi M; Alessi N; Resta ML; Ferraù O
    Hepatogastroenterology; 2002; 49(47):1382-5. PubMed ID: 12239947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokines for the treatment of thrombocytopenia.
    Ciurea SO; Hoffman R
    Semin Hematol; 2007 Jul; 44(3):166-82. PubMed ID: 17631181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thrombocytopenia in HCV infection. Natural interferon as an alternative therapy].
    Krzowska-Firych J; Modrzewska R; Kiciak SG
    Przegl Epidemiol; 2007; 61(4):771-6. PubMed ID: 18572510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Retreatment of patients with chronic hepatitis C].
    Ostojić R
    Acta Med Croatica; 2005; 59(5):447-51. PubMed ID: 16381242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Have hematopoietic growth factors made an impact on the management of liver disease?
    Tyagi P; Madan K
    Trop Gastroenterol; 2008; 29(4):187-93. PubMed ID: 19323086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of thrombocytopenia with disappearance of HCV RNA in patients treated by interferon-alpha therapy: possible etiology of HCV-associated immune thrombocytopenia.
    Iga D; Tomimatsu M; Endo H; Ohkawa S; Yamada O
    Eur J Haematol; 2005 Nov; 75(5):417-23. PubMed ID: 16191092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review article: thrombocytopenia in chronic liver disease.
    Poordad F
    Aliment Pharmacol Ther; 2007 Nov; 26 Suppl 1():5-11. PubMed ID: 17958514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human thrombopoietin clinical development.
    Jones DV; Ashby M; Vadhan-Raj S; Somlo G; Champlin R; Gajewski J; Hellmann S; Fyfe G
    Stem Cells; 1998; 16 Suppl 2():199-206. PubMed ID: 11012192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strong association of hepatitis C virus (HCV) infection and thrombocytopenia: implications from a survey of a community with hyperendemic HCV infection.
    Wang CS; Yao WJ; Wang ST; Chang TT; Chou P
    Clin Infect Dis; 2004 Sep; 39(6):790-6. PubMed ID: 15472809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of fibrosis in HIV and hepatitis C virus-coinfected patients treated with interferon plus ribavirin-based therapy: analysis of risk factors.
    Bani-Sadr F; Lapidus N; Bedossa P; De Boever CM; Perronne C; Halfon P; Pol S; Carrat F; Cacoub P; ;
    Clin Infect Dis; 2008 Mar; 46(5):768-74. PubMed ID: 18248298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombocytopenia in Patients with Chronic Hepatitis C Virus Infection.
    Dahal S; Upadhyay S; Banjade R; Dhakal P; Khanal N; Bhatt VR
    Mediterr J Hematol Infect Dis; 2017; 9(1):e2017019. PubMed ID: 28293407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombopoietin receptor agonists and risk of portal vein thrombosis in patients with liver disease and thrombocytopenia: A meta-analysis.
    Loffredo L; Violi F
    Dig Liver Dis; 2019 Jan; 51(1):24-27. PubMed ID: 29958825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Advance in thrombopoietic drugs used in treatment of children's immune thrombocytopenia].
    Ma JY; Wu RH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1513-7. PubMed ID: 23257464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombocytopenia in liver disease.
    Giannini EG; Savarino V
    Curr Opin Hematol; 2008 Sep; 15(5):473-80. PubMed ID: 18695370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.